APA (7th ed.) Citation

Yang, S., Wang, C., Chen, K., Liu, Y., Lin, C., Chuang, C., . . . Tsai, M. (2021). Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma. BMC Cancer, 21(1), 1. https://doi.org/10.1186/s12885-021-07796-7

Chicago Style (17th ed.) Citation

Yang, Shih-Yu, et al. "Statin Use Is Associated with a Lower Risk of Recurrence After Curative Resection in BCLC Stage 0-A Hepatocellular Carcinoma." BMC Cancer 21, no. 1 (2021): 1. https://doi.org/10.1186/s12885-021-07796-7.

MLA (9th ed.) Citation

Yang, Shih-Yu, et al. "Statin Use Is Associated with a Lower Risk of Recurrence After Curative Resection in BCLC Stage 0-A Hepatocellular Carcinoma." BMC Cancer, vol. 21, no. 1, 2021, p. 1, https://doi.org/10.1186/s12885-021-07796-7.